Sol-Gel Technologies (SLGL) Profit After Tax (2017 - 2026)
Sol-Gel Technologies (SLGL) reported Profit After Tax of $3.7 million for Q1 2026, down 57.69% year-over-year from $8.8 million in Q1 2025, and up 140.22% quarter-over-quarter from -$9.3 million in Q4 2025.
Sol-Gel Technologies (SLGL) Profit After Tax (2017 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 10 years of Profit After Tax data on file, last reported at $3.7 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at $3.7 million, down 57.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $128000.0 (up 102.61% YoY), and the FY2025 annual result was -$6.1 million, up 42.09% from the prior year.
- Profit After Tax improved to $3.7 million in Q1 2026 per SLGL's latest filing, from -$9.3 million in the prior quarter.
- Over five years, Profit After Tax peaked at $11.6 million in Q2 2025 and troughed at -$15.3 million in Q4 2024.
- A 5-year average of $922411.8 and a median of $2.0 million in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2023 and 2025: Profit After Tax jumped 4355.22% in 2023, then slumped 1523.5% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$5.8 million in 2022, then climbed by 16.4% to -$4.8 million in 2023, then tumbled by 216.67% to -$15.3 million in 2024, then soared by 39.49% to -$9.3 million in 2025, then soared by 140.22% to $3.7 million in 2026.
- Business Quant data shows SLGL's Profit After Tax at $3.7 million in Q1 2026, -$9.3 million in Q4 2025, and -$5.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - | 3.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.73 Mn |
| Dec 31, 2025 | -9.27 Mn |
| Sep 30, 2025 | -5.94 Mn |
| Jun 30, 2025 | 11.61 Mn |
| Mar 31, 2025 | 8.81 Mn |
| Dec 31, 2024 | -15.31 Mn |
| Sep 30, 2024 | -366,000.00 |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 6.34 Mn |
| Dec 31, 2023 | -4.84 Mn |
| Sep 30, 2023 | 5.71 Mn |
| Jun 30, 2023 | 5.97 Mn |
| Mar 31, 2023 | 10.72 Mn |
| Dec 31, 2022 | -5.79 Mn |
| Sep 30, 2022 | -3.41 Mn |
| Jun 30, 2022 | 134,000.00 |
| Mar 31, 2022 | 5.60 Mn |
| Dec 31, 2021 | -7.59 Mn |
| Sep 30, 2021 | 1.29 Mn |
| Jun 30, 2021 | 8.03 Mn |